Found: 127
Select item for more details and to access through your institution.
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. 431, doi. 10.1093/oncolo/oyad320
- By:
- Publication type:
- Article
Implementation of Best Practices in Pancreatic Cancer Care in the Netherlands: A Stepped-Wedge Randomized Clinical Trial.
- Published in:
- JAMA Surgery, 2024, v. 159, n. 4, p. 429, doi. 10.1001/jamasurg.2023.7872
- By:
- Publication type:
- Article
The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma.
- Published in:
- Brain Communications, 2024, v. 6, n. 4, p. 1, doi. 10.1093/braincomms/fcae241
- By:
- Publication type:
- Article
Reversal of Orally Induced T-Cell Tolerance by Subcutaneous Administration of Interleukin-12 at the Site of Attempted Sensitization.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 795, n. 1, p. 403, doi. 10.1111/j.1749-6632.1996.tb52706.x
- By:
- Publication type:
- Article
Medical knowledge and clinical productivity: independently correlated metrics during radiology residency.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition.
- Published in:
- Rheumatology, 2016, v. 55, n. 6, p. 1143, doi. 10.1093/rheumatology/kew063
- By:
- Publication type:
- Article
Proteasome inhibitor MG132 sensitizes HPV-positive human cervical cancer cells to rhTRAIL-induced apoptosis.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 8, p. 1892, doi. 10.1002/ijc.21580
- By:
- Publication type:
- Article
Imatinib induces hypothyroidism in patients receiving levothyroxine
- Published in:
- Clinical Pharmacology & Therapeutics, 2005, v. 78, n. 4, p. 433, doi. 10.1016/j.clpt.2005.06.010
- By:
- Publication type:
- Article
Self‐Targeted Co‐Delivery of an Antibiotic and a Cancer‐Chemotherapeutic from Synthetic Liposomes for the Treatment of Infected Tumors.
- Published in:
- Advanced Functional Materials, 2023, v. 33, n. 32, p. 1, doi. 10.1002/adfm.202215153
- By:
- Publication type:
- Article
Long-Term Survival in Patients With Advanced Melanoma.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2426641, doi. 10.1001/jamanetworkopen.2024.26641
- By:
- Publication type:
- Article
Contextual Structured Reporting in Radiology: Implementation and Long-Term Evaluation in Improving the Communication of Critical Findings.
- Published in:
- Journal of Medical Systems, 2020, v. 44, n. 9, p. N.PAG, doi. 10.1007/s10916-020-01609-3
- By:
- Publication type:
- Article
Neuroinflammation in Schizophrenia-Related Psychosis: A PET Study.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 11, p. 1801, doi. 10.2967/jnumed.109.066647
- By:
- Publication type:
- Article
<sup>18</sup>F-Dihydroxyphenylalanine PET in Patients with Biochemical Evidence of Medullary Thyroid Cancer: Relation to Tumor Differentiation.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 4, p. 524, doi. 10.2967/jnumed.107.047720
- By:
- Publication type:
- Article
Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 20, p. 10902, doi. 10.3390/ijms222010902
- By:
- Publication type:
- Article
Comparison of FAIR perfusion kinetics with DSC-MRI and functional histology in a model of transient ischemia.
- Published in:
- Magnetic Resonance in Medicine, 2004, v. 51, n. 2, p. 312, doi. 10.1002/mrm.10691
- By:
- Publication type:
- Article
Characterization, expression and complex formation of the murine Fanconi anaemia gene product Fancg.
- Published in:
- Genes to Cells, 2002, v. 7, n. 3, p. 333, doi. 10.1046/j.1365-2443.2002.00518.x
- By:
- Publication type:
- Article
Optimal regimes for local IL-2 tumour therapy.
- Published in:
- International Journal of Cancer, 1996, v. 66, n. 3, p. 400, doi. 10.1002/(SICI)1097-0215(19960503)66:3<400::AID-IJC22>3.0.CO;2-D
- By:
- Publication type:
- Article
Effect of immunomodulators on specific tumor immunity induced by liposome-encapsulated tumor-associated antigens.
- Published in:
- International Journal of Cancer, 1994, v. 56, n. 5, p. 721, doi. 10.1002/ijc.2910560518
- By:
- Publication type:
- Article
First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221077088
- By:
- Publication type:
- Article
Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211033704
- By:
- Publication type:
- Article
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 1, p. 573, doi. 10.1245/s10434-022-12600-2
- By:
- Publication type:
- Article
ASO Author Reflections: Intensified Neoadjuvant Chemoradiotherapy Followed by Esophagectomy in Esophageal Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 5, p. 1529, doi. 10.1245/s10434-020-08276-1
- By:
- Publication type:
- Article
Intensified Neoadjuvant Chemoradiotherapy for Patients with Potentially Resectable Esophageal Cancer: A Retrospective Cohort Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 5, p. 1520, doi. 10.1245/s10434-019-08114-z
- By:
- Publication type:
- Article
Early Recurrence in Completely Resected IIIB and IIIC Melanoma Warrants Restaging Prior to Adjuvant Therapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 12, p. 3945, doi. 10.1245/s10434-019-07274-2
- By:
- Publication type:
- Article
Failure to validate existing clinical prediction scale for response to PD-1 monotherapy in advanced melanoma in national cohort study.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Correction: First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
First-line BRAF/MEK inhibitors versus anti-PD-1 monotherapy in BRAF<sup>V600</sup>-mutant advanced melanoma patients: a propensity-matched survival analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy.
- Published in:
- Cancer & Metastasis Reviews, 2020, v. 39, n. 3, p. 999, doi. 10.1007/s10555-020-09876-9
- By:
- Publication type:
- Article
The impact of frontal lesions after mild to moderate traumatic brain injury on frontal network measures.
- Published in:
- PLoS ONE, 2023, v. 18, n. 11, p. 1, doi. 10.1371/journal.pone.0287832
- By:
- Publication type:
- Article
High predictability of impaired glucose tolerance by combining cardiometabolic screening parameters in obese children.
- Published in:
- Journal of Pediatric Endocrinology & Metabolism, 2017, v. 30, n. 2, p. 189, doi. 10.1515/jpem-2016-0289
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted <sup>227</sup>Th-Conjugate Therapy in Mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 11, p. 1715, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging 1 reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging 1 reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
<sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263079
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Mesothelin/CD3 half-life extended bispecific T-cell engager molecule shows specific tumor uptake and distributes to mesothelin and CD3 expressing tissues.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.259036
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.241877
- By:
- Publication type:
- Article
Biodistribution of a CD3/EpCAM bispecific T-cell engager is driven by the CD3 arm.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.24187
- By:
- Publication type:
- Article